Not a good buy right now for an impatient investor: momentum is weakening into an earnings event (2026-02-10) while the stock sits below the key pivot (116.78).
Longer-term trend is still constructive (bullish moving-average stack), but near-term risk/reward is unfavorable given bearish MACD expansion and heavy put volume.
Better entry would typically be after earnings clarity or on a cleaner reclaim of the pivot; as of now, the setup is “wait/hold,” not “buy now.”
Technical Analysis
Trend: Medium/long-term trend remains bullish (SMA_5 > SMA_20 > SMA_200), but near-term momentum is deteriorating.
MACD: Histogram -0.932 and negatively expanding → bearish momentum building.
RSI(6): 41.99 (neutral-to-soft) → not oversold; lacks a strong rebound signal.
Levels: Price 113.01 is below Pivot 116.78 (bearish positioning). Key support S1 110.90 then S2 107.26; resistance R1 122.66.
Practical read: The chart suggests downside testing risk toward 110.9 before a higher-probability long entry appears.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning (Open Interest): Put/Call OI = 0.32 → call-heavy open interest (typically bullish longer-horizon positioning).
Flow (Volume): Put/Call Volume = 7.48 with put volume 1070 vs call volume 143 → strong near-term demand for puts (protective hedging or bearish bets).
Volatility: IV 30d = 75.27; IV percentile = 93.23 → options are very expensive, consistent with event risk (earnings soon).
Takeaway: Sentiment is mixed—structurally bullish OI but tactically defensive/bearish volume into earnings.
Technical Summary
Sell
1
Buy
13
Positive Catalysts
Earnings catalyst: QDEC 2025 earnings on 2026-02-10 (pre-market) with Street EPS est. 0.67; upside surprise could reverse the current momentum softness.
Analyst upside remains: Multiple Buy/Outperform ratings with raised targets (UBS/Needham/Citi up to $145–$150), citing end-market recovery and AI exposure.
Technical backdrop: Bullish moving-average structure suggests dips may still be bought if support holds (110.9 area).
Neutral/Negative Catalysts
Momentum warning: MACD is bearish and worsening while price remains below the pivot (116.78).
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: $807.1M, -0.07% YoY (flat to slightly down).
Net income: $70.5M, -9.13% YoY.
EPS: $0.46, -9.80% YoY.
Gross margin: 37.83%, -6.15% YoY.
Growth read: Top line stalled while profitability/margins declined—this raises the bar for the upcoming QDEC 2025 report to re-accelerate earnings quality.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend (last ~2 weeks): Mixed—several large price-target raises and Buy reiterations (UBS $150 Buy; Citi $145 Buy; Needham $150 Strong Buy; BMO $126 Outperform) alongside notable downgrades (Deutsche to Hold $105; Seaport to Neutral).
Wall Street pros: Improving semicap fundamentals, AI-related demand tailwinds, and potential for margin improvement in a recovery.
Wall Street cons: Concerns about positioning to capture upside and limited margin improvement (echoed by prior Goldman Sell stance) plus valuation/crosscurrents after a strong run.
Influential/political flows: No recent congress trading data; hedge funds and insiders show neutral recent activity.
Wall Street analysts forecast ENTG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENTG is 98.29 USD with a low forecast of 75 USD and a high forecast of 115 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast ENTG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENTG is 98.29 USD with a low forecast of 75 USD and a high forecast of 115 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 110.330
Low
75
Averages
98.29
High
115
Current: 110.330
Low
75
Averages
98.29
High
115
Deutsche Bank
Buy
to
Hold
downgrade
$105
AI Analysis
2026-02-03
New
Reason
Deutsche Bank
Price Target
$105
AI Analysis
2026-02-03
New
downgrade
Buy
to
Hold
Reason
Deutsche Bank downgraded Entegris to Hold from Buy with a $105 price target. Following the 35% rise in the stock year-to-date, the firm is reducing its rating to reflect the "crosscurrents", though it remains hopeful that the new management adapts the company's strategy to drive strong revenue and earnings growth in the near term, the analyst tells investors in a research note.
UBS
Buy
maintain
$145 -> $150
2026-02-02
Reason
UBS
Price Target
$145 -> $150
2026-02-02
maintain
Buy
Reason
UBS raised the firm's price target on Entegris to $150 from $145 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ENTG
